Article
GSK's RSV vaccine first to get EU regulator's nod
Rating:
0.0
Views:
50
Likes:
1
Library:
1
The European Medicines Agency (EMA) on Wednesday recommended authorization of GSK's Arexvy vaccine for respiratory syncytial virus (RSV) in adults aged 60 and older, putting Europe on track to approve the world's first such vaccine.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value